94 related articles for article (PubMed ID: 9127830)
41. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
[TBL] [Abstract][Full Text] [Related]
42. Effects of fluoxetine on the polysomnogram in outpatients with major depression.
Trivedi MH; Rush AJ; Armitage R; Gullion CM; Grannemann BD; Orsulak PJ; Roffwarg HP
Neuropsychopharmacology; 1999 May; 20(5):447-59. PubMed ID: 10192825
[TBL] [Abstract][Full Text] [Related]
43. Elevated cholesterol levels associated with nonresponse to fluoxetine treatment in major depressive disorder.
Sonawalla SB; Papakostas GI; Petersen TJ; Yeung AS; Smith MM; Sickinger AH; Gordon J; Israel JA; Tedlow JR; Lamon-Fava S; Fava M
Psychosomatics; 2002; 43(4):310-6. PubMed ID: 12189257
[TBL] [Abstract][Full Text] [Related]
44. [Seizures crisis following sudden stop of fluoxetine].
Epelde F; Plà R; Aguilar M
Med Clin (Barc); 1999 Oct; 113(12):479. PubMed ID: 10570524
[No Abstract] [Full Text] [Related]
45. What constitutes an adequate antidepressant trial for fluoxetine?
Schweizer E; Rickels K; Amsterdam JD; Fox I; Puzzuoli G; Weise C
J Clin Psychiatry; 1990 Jan; 51(1):8-11. PubMed ID: 2403998
[TBL] [Abstract][Full Text] [Related]
46. Cognitive therapy versus fluoxetine in the treatment of dysthymic disorder.
Dunner DL; Schmaling KB; Hendrickson H; Becker J; Lehman A; Bea C
Depression; 1996; 4(1):34-41. PubMed ID: 9160652
[TBL] [Abstract][Full Text] [Related]
47. Differential effects of trimipramine and fluoxetine on sleep in geriatric depression.
Wolf R; Dykierek P; Gattaz WF; Maras A; Kohnen R; Dittmann RW; Geuppert M; Riemann D; Berger M
Pharmacopsychiatry; 2001 Mar; 34(2):60-5. PubMed ID: 11302565
[TBL] [Abstract][Full Text] [Related]
48. Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline.
Joyce PR; Mulder RT; Luty SE; Sullivan PF; McKenzie JM; Abbott RM; Stevens IF
Aust N Z J Psychiatry; 2002 Jun; 36(3):384-91. PubMed ID: 12060188
[TBL] [Abstract][Full Text] [Related]
49. Is anxious-agitated major depression responsive to fluoxetine? A double-blind comparison with amitriptyline.
Marchesi C; Ceccherininelli A; Rossi A; Maggini C
Pharmacopsychiatry; 1998 Nov; 31(6):216-21. PubMed ID: 9930635
[TBL] [Abstract][Full Text] [Related]
50. The effect of fluoxetine on anxiety and depression symptoms in cancer patients.
Razavi D; Allilaire JF; Smith M; Salimpour A; Verra M; Desclaux B; Saltel P; Piollet I; Gauvain-Piquard A; Trichard C; Cordier B; Fresco R; Guillibert E; Sechter D; Orth JP; Bouhassira M; Mesters P; Blin P
Acta Psychiatr Scand; 1996 Sep; 94(3):205-10. PubMed ID: 8891089
[TBL] [Abstract][Full Text] [Related]
51. Vulnerability to fluoxetine-induced indifference syndrome among opiate addicts: a case report.
Bertschy G; Baumann P
Biol Psychiatry; 1995 Sep; 38(6):404-6. PubMed ID: 8547460
[No Abstract] [Full Text] [Related]
52. Are neurovegetative symptoms stable in relapsing or recurrent atypical depressive episodes?
Nierenberg AA; Pava JA; Clancy K; Rosenbaum JF; Fava M
Biol Psychiatry; 1996 Oct; 40(8):691-6. PubMed ID: 8894060
[TBL] [Abstract][Full Text] [Related]
53. Right hemisphere abnormalities in major depression: quantitative electroencephalographic findings before and after treatment.
Kwon JS; Youn T; Jung HY
J Affect Disord; 1996 Oct; 40(3):169-73. PubMed ID: 8897116
[TBL] [Abstract][Full Text] [Related]
54. [A comparative clinical evaluation of the antidepressive activity of fluoxetine and fluvoxamine].
Lopukhov IG
Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(4):53-7. PubMed ID: 9214192
[TBL] [Abstract][Full Text] [Related]
55. Predictors of fluoxetine remission for hospitalized patients with major depressive disorder.
Lin CH; Lane HY; Chen CC; Juo SH; Yen CF
Psychiatry Clin Neurosci; 2011 Aug; 65(5):510-7. PubMed ID: 21851460
[TBL] [Abstract][Full Text] [Related]
56. Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome.
Vercoulen JH; Swanink CM; Zitman FG; Vreden SG; Hoofs MP; Fennis JF; Galama JM; van der Meer JW; Bleijenberg G
Lancet; 1996 Mar; 347(9005):858-61. PubMed ID: 8622391
[TBL] [Abstract][Full Text] [Related]
57. [A test for using meta-analysis to evaluate antidepressive effects of fluoxetine].
Jarema M
Psychiatr Pol; 1996; 30(4):569-81. PubMed ID: 8975258
[TBL] [Abstract][Full Text] [Related]
58. Dichotic listening tests of functional brain asymmetry predict response to fluoxetine in depressed women and men.
Bruder GE; Stewart JW; McGrath PJ; Deliyannides D; Quitkin FM
Neuropsychopharmacology; 2004 Sep; 29(9):1752-61. PubMed ID: 15238992
[TBL] [Abstract][Full Text] [Related]
59. An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression.
Trivedi MH; Thase ME; Osuntokun O; Henley DB; Case M; Watson SB; Campbell GM; Corya SA
J Clin Psychiatry; 2009 Mar; 70(3):387-96. PubMed ID: 19284928
[TBL] [Abstract][Full Text] [Related]
60. Psychomotor monitoring: a promise being fulfilled?
Greden JF
J Psychiatr Res; 1993; 27(3):285-7. PubMed ID: 8295160
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
